249 related articles for article (PubMed ID: 1391038)
1. Ex vivo gene therapy of familial hypercholesterolemia.
Wilson JM; Grossman M; Raper SE; Baker JR; Newton RS; Thoene JG
Hum Gene Ther; 1992 Apr; 3(2):179-222. PubMed ID: 1391038
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.
Chowdhury JR; Grossman M; Gupta S; Chowdhury NR; Baker JR; Wilson JM
Science; 1991 Dec; 254(5039):1802-5. PubMed ID: 1722351
[TBL] [Abstract][Full Text] [Related]
4. Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
Shichiri M; Tanaka A; Hirata Y
Gene Ther; 2003 May; 10(9):827-31. PubMed ID: 12704424
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity.
Grossman M; Raper SE; Wilson JM
Hum Gene Ther; 1992 Oct; 3(5):501-10. PubMed ID: 1420448
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit.
Wiederkehr JC; Kondos GT; Pollak R
Transplantation; 1990 Sep; 50(3):466-71. PubMed ID: 2144923
[TBL] [Abstract][Full Text] [Related]
7. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.
Wilson JM; Chowdhury NR; Grossman M; Wajsman R; Epstein A; Mulligan RC; Chowdhury JR
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8437-41. PubMed ID: 2236051
[TBL] [Abstract][Full Text] [Related]
8. Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Tanaka M; Otani H; Yokode M; Kita T
Atherosclerosis; 1995 Apr; 114(1):73-82. PubMed ID: 7605378
[TBL] [Abstract][Full Text] [Related]
9. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives.
Sanna C; Stéphenne X; Revencu N; Smets F; Sassolas A; Di Filippo M; Descamps OS; Sokal EM
Atherosclerosis; 2016 Apr; 247():97-104. PubMed ID: 26894473
[TBL] [Abstract][Full Text] [Related]
10. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
11. Pathobiology of familial hypercholesterolemic atherosclerosis.
Aliev G; Castellani RJ; Petersen RB; Burnstock G; Perry G; Smith MA
J Submicrosc Cytol Pathol; 2004; 36(3-4):225-40. PubMed ID: 15906597
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
Schmidt HH; Tietge UJ; Buettner J; Barg-Hock H; Offner G; Schweitzer S; Dedoussis GV; Rodeck B; Kallfelz HC; Schlitt HJ; Oldhafer K; Klempnauer J
Clin Transplant; 2008; 22(2):180-4. PubMed ID: 18339137
[TBL] [Abstract][Full Text] [Related]
13. Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro.
Goulinet-Mainot S; Tranchart H; Groyer-Picard MT; Lainas P; Saloum Diop P; Holopherne D; Gonin P; Benihoud K; Ba N; Gauthier O; Franco D; Guettier C; Pariente D; Weber A; Dagher I; Huy Nguyen T
Cell Med; 2012 Feb; 4(2):85-98. PubMed ID: 26858856
[TBL] [Abstract][Full Text] [Related]
14. [Perspective of gene therapy in hyperlipoproteinemia].
Ishibashi S; Yamada N
Nihon Rinsho; 1994 Dec; 52(12):3303-8. PubMed ID: 7853727
[TBL] [Abstract][Full Text] [Related]
15. A genetic therapy for familial hypercholesterolemia.
Dichek DA; Bratthauer GL; Beg ZH; Newman KD; Anderson KD; Zwiebel JA; Hoeg JM; Anderson WF
Trans Assoc Am Physicians; 1990; 103():73-9. PubMed ID: 2132544
[TBL] [Abstract][Full Text] [Related]
16. Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia.
Havel RJ; Yamada N; Shames DM
Arteriosclerosis; 1989; 9(1 Suppl):I33-8. PubMed ID: 2643428
[TBL] [Abstract][Full Text] [Related]
17. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.
Raper SE; Grossman M; Rader DJ; Thoene JG; Clark BJ; Kolansky DM; Muller DW; Wilson JM
Ann Surg; 1996 Feb; 223(2):116-26. PubMed ID: 8597504
[TBL] [Abstract][Full Text] [Related]
18. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse.
Tomita N; Morishita R; Koike H; Hashizume M; Notake M; Fujitani B; Kaneda Y; Horiuchi M; Ogihara T
Int J Mol Med; 2002 Aug; 10(2):137-43. PubMed ID: 12119548
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of genetically modified hepatocytes after liver preconditioning in Watanabe heritable hyperlipidemic rabbit.
Tranchart H; Gaillard M; Diop PS; Goulinet S; Lainas P; Dagher I
J Surg Res; 2018 Apr; 224():23-32. PubMed ID: 29506845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
